GlassScriptPhysician profile
Robert S Sterling
NPI 1396782603
$37,563.65
in general payments reported to CMS, 2019-2025
16 companies · $1,991 in 2025
The $1,991 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,586 · 2020: $2,731 · 2021: $391 · 2022: $27K · 2023: $2,613 · 2024: $1,019 · 2025: $1,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,007 · Travel and Lodging: $2,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,007.15 |
| Travel and Lodging | $2,615.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $16,230.08 | 2019-2025 | Oxford |
| Smith+Nephew, INC. | $13,954.67 | 2019-2025 | |
| Regeneron Pharmaceuticals, INC. | $2,660.00 | 2020 | |
| Encore Medical, LP | $2,550.81 | 2022-2025 | Djo Surgical |
| Microport Orthopedics INC | $536.50 | 2025 | Mpo Medial Pivot Knee |
| Stryker Corporation | $350.57 | 2022-2025 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex |
| Supreme Orthopedic Systems, LLC | $210.59 | 2023-2025 | |
| Ethicon US, LLC | $160.97 | 2023-2025 | Stratafix, Dermabond Prineo, Surgiflo Hemostatic Matrix |
| Medacta USA, INC. | $150.44 | 2024 | |
| Davol INC. | $150.30 | 2025 | |
| Biocomposites INC | $142.86 | 2024 | |
| Depuy Synthes Sales INC. | $141.83 | 2024 | Na |
| Integra Lifesciences Corporation | $141.02 | 2023 | Tenoglide |
| Si-Bone, INC. | $133.42 | 2024 | |
| Arteriocyte Medical Systems, INC. | $25.28 | 2023 | Magellan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $24.31 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sterling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.